Hyperbranched cationic polysaccharide derivatives for efficient siRNA delivery and diabetic wound healing enhancement

Int J Biol Macromol. 2020 Jul 1:154:855-865. doi: 10.1016/j.ijbiomac.2020.03.164. Epub 2020 Mar 18.

Abstract

Gene vectors are important for successful siRNA delivery. Four types of hyperbranched cationic polysaccharide derivatives (HCP) were synthesized by conjuncting 1,2-ethylenediamine (EDA) and diethylenetriamine (DETA) with glycogen or amylopectin respectively and named as G-EDA, G-DETA, A-EDA and A-DETA. The efficiency and safety of these HCPs to deliver siRNA were explored in vitro and in vivo. Our results showed that HCPs could form complexes with siRNA. All HCP/siRNA exhibited negligible cytotoxicity. Compared with A-EDA and A-DETA, G-EDA and G-DETA could carry much more siRNA into cells and then escape from endosomes. The delivery of MMP-9 siRNA (siMMP-9) by G-EDA and G-DETA significantly inhibited MMP-9 in HaCaT cells. Wound models in diabetic rats demonstrated that treatment of G-EDA/siMMP-9 could potently knock down MMP-9 of skin wound tissues and then enhanced wound healing. In summary, this study provided an effective and safe approach for siRNA delivery in vitro and in vivo.

Keywords: Hyperbranched cationic polysaccharide derivatives; Matrix metalloproteinase-9 (MMP-9); Wound healing; siRNA delivery.

MeSH terms

  • Animals
  • Diabetes Mellitus, Experimental / therapy*
  • Drug Carriers*
  • Gene Knockdown Techniques
  • HaCaT Cells
  • Humans
  • Matrix Metalloproteinase 9 / genetics*
  • Polysaccharides*
  • RNA, Small Interfering*
  • Rats
  • Rats, Sprague-Dawley
  • Wound Healing*

Substances

  • Drug Carriers
  • Polysaccharides
  • RNA, Small Interfering
  • MMP9 protein, human
  • Matrix Metalloproteinase 9